Nantahala Capital Management, LLC 13D and 13G filings for Lyra Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-14 4:53 pm Sale |
2024-09-30 | 13G | Lyra Therapeutics, Inc. LYRA |
Nantahala Capital Management, LLC | 702,106 1.061% |
-4,050,218 (-85.23%) |
Filing |
| 2024-02-14 4:51 pm Purchase |
2023-12-31 | 13G | Lyra Therapeutics, Inc. LYRA |
Nantahala Capital Management, LLC | 4,752,324 8.900% |
2,531,494 (+113.99%) |
Filing |
| 2023-02-14 4:48 pm Purchase |
2022-12-31 | 13G | Lyra Therapeutics, Inc. LYRA |
Nantahala Capital Management, LLC | 2,220,830 7.000% |
2,220,830 (New Position) |
Filing |